LEVY Health Secures $4.5M in Funding to Bridge the Reproductive Care Gap by Empowering Providers

In the evolving field of reproductive health, timely diagnosis and effective treatment are critical. Yet, millions of individuals struggling with fertility are often left waiting far too long for care. LEVY Health, an innovative player in reproductive health technology, has secured $4.5 million in funding led by XYZ Venture Capital, alongside Atlantic Labs and Possible Ventures. This marks a pivotal moment in advancing the company’s mission to close the reproductive care gap—especially for fertility clinics, women’s health providers, biopharma, laboratories, and other industry players.

At the heart of LEVY Health’s solution is a clinical decision support engine and a comprehensive platform that offers virtual care pathways. The solution is capable of reducing the time to diagnosis and treatment from years to weeks. The recent funding will accelerate LEVY Health’s growth and enable seamless integration with electronic medical record systems (EMRs), empowering healthcare providers to deliver faster, more personalized care.

Women’s healthcare providers are often faced with significant hurdles: often patients arrive unprepared to their first visits, resulting in lengthy treatment timelines; staff shortages and provider burnout make it increasingly difficult to deliver timely care; and the constant administrative burden leaves less time for what really matters—patient care and treatment.

LEVY Health’s platform is designed to address these challenges head-on. By automating processes such as patient intake, lab ordering, diagnostics, triaging, and education, the software enables providers to accelerate their patients’ journey to treatment. Physicians are presented with well-prepared patients at the initial consultation with patients who arrive educated, equipped with the necessary knowledge, and ready to make informed decisions about their treatment options.

For fertility clinics, which face a well-known shortage of reproductive endocrinologists across the U.S., efficiency is crucial. From initial testing to patient readiness for treatment, delays often hinder conversion rates. LEVY Health offers a solution by reducing time-to-treatment from an average of 145 days to just 45 days. Clinics using the platform for fertility work-ups see better-prepared patients at their first visit, resulting in fewer appointments and a more engaged, proactive patient base. This leads to higher treatment conversion rates and smoother clinical workflows.

The platform also helps with patient triaging by automatically guiding lower-complexity cases to less resource-intensive pathways, while prioritizing higher-need cases. This enables clinics to manage staff and time more effectively, reducing physician burnout and optimizing the use of limited resources.

“We like to think of LEVY Health as a virtual care coordinator for fertility clinics,” says Caroline Mitterdorfer, CEO and Co-founder of LEVY Health. “Our platform takes care of everything from diagnostic work-ups to patient education, allowing providers to focus on treatment planning as early as the first consultation.”

Egg donor banks and agencies face unique challenges in triaging potential donors. LEVY Health’s pre-testing capabilities offer significant time and resource savings by automating the screening process. By filtering out ineligible donors early, the platform reduces operational costs and increases the conversion rate of eligible donors. Donors who are disqualified in the process learn about the reasons and potential consequences for their reproductive health. For donors who are eligible, LEVY Health issues individualized ovarian stimulation recommendations.

In a highly competitive landscape, fertility benefit providers need to deliver meaningful outcomes to employers. LEVY Health’s tailored diagnostic pathways for fertility and women’s health help these providers improve patient engagement, utilization rates, and overall satisfaction—all crucial metrics for employer ROI. By streamlining the fertility work-up, LEVY Health reduces time to treatment, enabling faster access to care for patients. The platform’s ability to seamlessly integrate virtual care support for those undergoing fertility treatment allows providers to expand their offerings, further differentiating themselves in a crowded market.

By partnering with LEVY Health, biopharma companies can leverage real-world patient data to inform their commercialization strategies and patient segmentation. The partnership offers a direct way to support lifecycle management of existing products while also providing a wraparound service that increases patient retention and adherence to prescribed treatments.

“We see this as a game-changer for biopharma companies looking to build a stronger presence in women’s health,” says Mitterdorfer. “By working with LEVY Health, companies can drive script volume, differentiate their products, and ultimately deliver better outcomes for patients.”

With increasing pricing pressures and competition, labs are looking for ways to differentiate themselves. LEVY Health’s algorithms ensure personalized, risk-based test selection in both B2B2B and B2B2C setups. By providing actionable results interpretation for laboratories’ clients, labs are able to retain and grow their customer base. Additionally, LEVY Health’s wraparound services—ranging from diagnostics to patient education—enable lab providers to offer a more comprehensive package to their healthcare customers, driving retention and test volume.

As the global fertility market continues to grow—estimated to reach $62.8 billion by 2033—the demand for efficiency, precision, and scalability in reproductive health solutions is more urgent than ever. Clinics, providers, and industry players alike are turning to technology to meet these demands, creating a unique opportunity for LEVY Health.

“We’re incredibly excited about what the future holds,” says Mitterdorfer. “This new funding will help us expand our offerings and continue to build solutions that help our partners deliver better care faster, at lower costs.”

LEVY Health’s current partnerships with industry leaders such as Boston IVF, Progyny, and Everie demonstrate the company’s commitment to transforming reproductive health for the better. By leveraging cutting-edge technology and deep clinical expertise, LEVY Health is reshaping the way providers deliver care, and patients experience it.

This funding milestone is just the beginning for LEVY Health. With solutions tailored to the specific needs of fertility clinics, third-party providers, fertility benefit managers, biopharma, and laboratories, the company is well-positioned to become a critical partner in the future of reproductive care.

For clinics and healthcare providers interested in learning more about how LEVY Health can improve your practice’s efficiency and patient outcomes, reach out to schedule a demo.